BioSpace News Archive

Drug Development

Can-Fite BioPharma Receives FDA Approval to Conduct Phase I Study With CF102

January 8, 2008
·
1 min read
Deals

Synovis Life Technologies, Inc. Announces Agreement to Sell Its Interventional Business for $29.5M Cash

January 8, 2008
·
5 min read
Biotech Bay

WaferGen, Inc. Completes Development of SmartChip(TM) Real-Time PCR System and Key Oncology Gene Panel Assays

January 8, 2008
·
8 min read
Deals

China Medical Technologies, Inc. Completes Acquisition of BBE

January 8, 2008
·
2 min read
Drug Development

Pluristem Therapeutics Announces Second Clinical Indication Revascularization Effect After PLX-PAD Therapy

January 8, 2008
·
1 min read
Genetown

Ariad Pharmaceuticals, Inc. Announces 2008 Key Corporate Objectives and Plans for Development of Its Lead Oncology Product Candidates

January 8, 2008
·
1 min read
Pharm Country

OSI Pharmaceuticals, Inc. Announces Conversion Period for Convertible Notes

January 8, 2008
·
1 min read
Drug Development

Emergent BioSolutions Announces That the Final Phase II Clinical Study Results for Typhoid Vaccine Reaffirms Clinical Endpoints Met; Immune Response Seen in 97% of Treated Subjects

January 8, 2008
·
1 min read
Business

Sanguine Corporation Supplies PHER-O2 to European Medical Research Group for Intravenous Development and Evaluation

January 8, 2008
·
1 min read
Drug Development

ZymoGenetics, Inc. Begins Phase 2 Trial in Renal Cell Cancer Evaluating IL-21 Combined with Nexavar(R)

January 8, 2008
·
1 min read